Medicamen Biotech Ltd.
| BSE: 531146 | Sector: Health care |
| NSE: MEDICAMEQ | ISIN Code: INE646B01010 |
| BSE 00:00 | 01 Jul | 670.95 |
0.85 (0.13%) |
OPEN
670.60 |
HIGH
686.55 |
LOW
667.25 |
| NSE 00:00 | 01 Jul | 673.15 |
3.70 (0.55%) |
OPEN
669.45 |
HIGH
682.80 |
LOW
660.10 |
| OPEN | 670.60 |
| PREVIOUS CLOSE | 670.10 |
| VOLUME | 406 |
| 52-Week high | 1023.25 |
| 52-Week low | 495.55 |
| P/E | 55.00 |
| Mkt Cap.(Rs cr) | 820 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Medicamen Biotech Ltd. (MEDICAMEQ) - Announcements
-
Medicamen Biotech Ltd Disclosure Under Regulations 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Reg
07/06/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
30/05/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
26/05/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
26/05/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Corporate Action-Board approves Dividend
25/05/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Outcome Of Board Meeting Held On 25.05.2022
25/05/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Board to consider Final Dividend
18/05/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Board Meeting Intimation for Approval Of Audited Financial Results Of The Company (Standalone & Cons
18/05/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
29/04/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure
28/04/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirement
18/04/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Compliance-Certificate Under Reg. 74 (5) Of SEBI (DP) Regulations 2018
18/04/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Compliance Under Regulation 40(10) Of SEBI LODR As On 31.03.2022.
18/04/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
18/04/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Statement Of Investor Complaints For The Quarter Ended March 2022
18/04/2022 | bse
-
Medicamen Biotech Ltd Clarification Sought On Price Movement
07/04/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Clarification sought from Medicamen Biotech Ltd
06/04/2022 | bse
-
Medicamen Biotech Ltd Closure of Trading Window
01/04/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
10/03/2022 | bse |
Downlaod PDF -
Medicamen Biotech Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
10/03/2022 | bse |
Downlaod PDF
Quick Links for Medicamen Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
